The influence of dopamine-beta hydroxylase and catechol O-methyltransferase 
gene polymorphism on the efficacy of insulin detemir therapy in patents with 
type 2 diabetes mellitus

Bozek, Tomislav; Blazekovic, Antonela; Nikolac Perkovic, Matea; Gotovac Jercic, Kristina; Sustar, Aleksandra; Smircic-Duvnjak, Lea; Outeiro, Tiago F.; Pivac, Nela; Borovecki, Fran

doi:10.1186/s13098-017-0295-0

Item

ITEM ACTIONSEXPORT

Add to Basket

Please note that a newer version of this item is available:
https://pure.mpg.de/pubman/item/item_2518054_5

DetailsSummary

Released

Journal Article

The influence of dopamine-beta hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patents with type 2 diabetes mellitus

MPS-Authors

/persons/resource/persons197309

Outeiro, Tiago F.
Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Bozek_17.pdf
(Publisher version), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Bozek, T., Blazekovic, A., Nikolac Perkovic, M., Gotovac Jercic, K., Sustar, A., Smircic-Duvnjak, L., et al. (2017). The influence of dopamine-beta hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patents with type 2 diabetes mellitus. Diabetology & Metabolic Syndrome, 9: 97. doi:10.1186/s13098-017-0295-0.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002E-976C-6

Abstract

There is no abstract available